PUBLISHER: The Business Research Company | PRODUCT CODE: 1957883
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957883
Transfection technologies involve the deliberate delivery of nucleic acids into cells through chemical, physical, or biological approaches to alter gene expression or genetic material. They are applied to investigate gene function, enable protein production, suppress gene activity through ribonucleic acid (RNA) interference such as siRNA or miRNA, and offer potential therapeutic applications by introducing functional genes to address genetic disorders.
The main types of transfection technology products include kits and reagents, equipment, and other related products. Kits and reagents for transfection technologies offer ready-to-use solutions that simplify the introduction of nucleic acids into cells for purposes such as gene expression and genome editing. This process is carried out using various transfection methods, including lipofection, electroporation, nucleofection, cotransfection, cationic lipid transfection, in-vivo transfection, and others, for a range of applications such as virus production, protein production, gene silencing, stem cell reprogramming and differentiation, stable cell line generation, therapeutic delivery, biomedical research, and more. These technologies are utilized by a variety of end-users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), academic and research institutes, among others.
Tariffs have increased the cost of imported transfection reagents, plasmid materials, and specialized laboratory equipment used in life science research workflows. These impacts are most pronounced in North America and Europe, where advanced research laboratories depend on global suppliers. Rising tariff related expenses have influenced research budgets and procurement planning across academic and commercial laboratories. This has affected purchasing cycles and experimentation timelines for cell and gene research. However, tariffs are also encouraging local manufacturing of life science research tools, regional supplier development, and greater self sufficiency in critical laboratory inputs.
The transfection technologies market research report is one of a series of new reports from The Business Research Company that provides transfection technologies market statistics, including transfection technologies industry global market size, regional shares, competitors with a transfection technologies market share, detailed transfection technologies market segments, market trends and opportunities, and any further data you may need to thrive in the transfection technologies industry. This transfection technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The transfection technologies market size has grown strongly in recent years. It will grow from $1.31 billion in 2025 to $1.42 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to growth in molecular biology research, advances in gene expression studies, expansion of protein production needs, increased funding for genomics research, early adoption in academic laboratories.
The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growth of cell and gene therapies, increasing rna therapeutics pipelines, rising investment in life sciences research, demand for efficient transfection reagents, expansion of personalized medicine. Major trends in the forecast period include rising demand for gene editing research tools, expansion of rna-based therapeutics development, increasing use in cell and gene therapy, growth in academic and biomedical research, advancement in non-viral transfection methods.
The growth of the transfection technologies market is expected to be driven by the increasing adoption of gene therapy in the coming years. Gene therapy is a method that seeks to treat or prevent diseases by altering genes, which may involve inserting, repairing, or replacing defective genes. The expansion of gene therapy is fueled by advancements in genetic research, improved delivery techniques, and its potential to address previously untreatable genetic disorders. Transfection technologies play a vital role in gene therapy by enabling the accurate, safe, and efficient delivery of genetic material into cells. They facilitate both temporary and permanent modifications to the genome, which are critical for treating genetic disorders and cancers. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, compared to five approvals in 2022. Consequently, the growth of gene therapy is propelling the expansion of the transfection technologies market.
Major companies in the transfection technologies market are concentrating on developing advanced solutions, such as mechanoporation transfection systems, to support more sophisticated and personalized applications in research and therapeutics. Mechanoporation transfection systems employ mechanical forces to create temporary pores in cell membranes, facilitating the entry of genetic material into cells. This technique is efficient and minimally invasive, maintaining higher cell viability. For example, in July 2024, STEMCELL Technologies, a Canada-based biotechnology firm, introduced CellPore, a novel transfection system. This system comprises a benchtop unit and the CellPore Transfection Kit 300, which includes a specialized reagent kit and single-use delivery cartridges. By using controlled, rapid deformation in microfluidic channels, CellPore effectively delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal disruption and high viability. These capabilities are essential for advancing research and the development of innovative cell and gene therapies.
In July 2023, Sartorius Stedim Biotec, a France-based company offering biopharmaceutical and life science research solutions, acquired Polyplus for an undisclosed sum. The acquisition is intended to strengthen Sartorius's biopharmaceutical capabilities by integrating innovative cell and gene therapy technologies. The deal expands Sartorius' portfolio with essential components such as transfection reagents, plasmid design, and protein manufacturing. Polyplus is a France-based producer of transfection reagents.
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the transfection technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The transfection technologies market consists of revenues earned by entities by providing services such as gene expression analysis, gene editing and therapy, and cell line development. The market value includes the value of related goods sold by the service provider or included within the service offering. The transfection technologies market also includes sales of transfection buffers, viral vectors, cell sorting and detection tools, and nanoparticles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Transfection Technologies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses transfection technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for transfection technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transfection technologies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.